Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Are endurance athletes at risk for hidden artery damage?

NCT ID NCT07419126

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will use ultrasound to check for medial arterial calcification (hardening of the arteries) in 60 healthy endurance athletes. The goal is to find out how common this condition is in this group and see if it relates to their training habits or heart risk factors. Participants are high-level athletes aged 18-70 who do over 5 hours of vigorous exercise weekly for more than 10 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy endurance athletes volunteering for the study, engaging in more than 5 hours of high-intensity endurance exercise per week for at least the past 10 years.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy volunteer attending a sports medicine consultation for the performance of an exercise stress test\*. * Male or female subject. * Age between 18 and 70 years, inclusive. * High-level endurance athlete, with regular practice of endurance sports (trail running, road running, cycling, swimming, cross-country skiing, biathlon), with a MET-min/week \> 2000, corresponding to more than 5 hours of vigorous physical activity per week, for more than 10 years. * Affiliated with a social security system. * No objection to participation in the study. \* Undergoing a lower limb arterial ultrasound examination as part of routine clinical care. Exclusion Criteria: * Participants with type 1 or type 2 diabetes mellitus. * Participants with chronic kidney disease, defined as an estimated glomerular filtration rate (eGFR) \< 60 mL/min/1.73 m². * Resting arterial hypertension. * Established cardiovascular disease (coronary artery disease, stroke, or peripheral arterial disease). * Protected or vulnerable populations as defined by French Public Health Code articles L1121-5 to L1121-8, including: pregnant or breastfeeding women, women in labor, individuals deprived of liberty by judicial or administrative decision, individuals receiving psychiatric care under articles L.3212-1 and L.3213-1, individuals admitted to healthcare or social institutions for purposes other than research, minors, individuals under legal protection, or individuals unable to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Calcifications vascular are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

calcinosis Vascular Calcification

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.